Healthleap raises $38 million to identify hospital risks

Healthleap has raised $38 million in seed and Series A funding, TechCrunch reports. The funding includes an $8 million round co-led by Sequoia Capital and First Round Capital, followed by a $30 million Series A led by Hummingbird Ventures. The valuation has not been disclosed.

The platform connects to the hospital's electronic health record. Language models extract information from clinical notes, including mentions of recent weight loss or difficulty swallowing. This information then feeds into risk models alongside structured data, such as laboratory results and vital signs. The company specifies that the software flags situations requiring further review, without making a diagnosis.

According to its leader, Healthleap is deployed in more than 50 hospitals to identify conditions including malnutrition and delirium. Other programs, covering aspiration pneumonia, pressure ulcers and the risk of readmission for congestive heart failure, are still undergoing clinical validation.

The technical challenge is to make notes written by healthcare staff usable in their daily work. But funding and deployment numbers are not enough to demonstrate a clinical benefit. The available information describes the claimed functionality and distinguishes current uses from programs still undergoing validation; it does not provide an independent assessment of the accuracy of the alerts.